Related Experiment Video
Updated: Feb 11, 2026

CRISPR/Cas9 Gene Editing of Hematopoietic Stem and Progenitor Cells for Gene Therapy Applications
Published on: August 9, 2022
A comprehensive meta-analysis of stem cell therapy for chronic angina
Rahman Shah1, Samuel B Latham1, Sajjad A Khan2
1Department of Internal Medicine, University of Tennessee, Memphis, Tennessee.
Insights
Stem cell therapy offers significant benefits for patients with chronic angina, improving symptoms and exercise capacity. While effective for angina, it did not impact mortality in this meta-analysis of randomized controlled trials.
Area of Science:
- Regenerative Medicine
- Cardiovascular Research
- Clinical Trials
Background:
- Many patients with coronary artery disease and refractory angina do not achieve full revascularization or symptom relief with optimal medical therapy.
- Stem cell therapy presents a promising therapeutic avenue for managing chronic angina.
- Previous studies on stem cell therapy for angina were limited by small sample sizes and insufficient statistical power.
Purpose of the Study:
- To conduct a comprehensive meta-analysis of randomized controlled trials (RCTs) to evaluate the efficacy of stem cell therapy in patients with chronic angina.
- To provide a robust assessment of stem cell therapy's impact on clinical outcomes in this patient population.
Main Methods:
- A systematic search of scientific databases and websites was performed to identify relevant RCTs.
- Data from 10 RCTs, involving a total of 658 patients, were independently collected and analyzed.
- Consensus was used to resolve any discrepancies in data collection.
Main Results:
- Stem cell therapy significantly improved Canadian Cardiovascular Society angina class (RR: 1.53, P=0.013) and exercise capacity (SMD: 0.56, P=0.001).
- Left ventricular ejection fraction (SMD: 0.63, P=0.001) and myocardial perfusion (SMD: -0.70, P=0.001) were enhanced, while anginal episodes decreased (SMD: -1.21, P=0.045).
- No significant improvement in all-cause mortality was observed during the follow-up period.
Conclusions:
- Stem cell therapy effectively improves symptoms, exercise tolerance, and cardiac function in patients with chronic angina receiving optimal medical care.
- The findings suggest that stem cell therapy is a viable option for managing chronic angina.
- Larger clinical trials are recommended to further validate these positive outcomes and assess long-term effects.
Background:
A substantial proportion of patients with coronary artery disease do not achieve complete revascularization and continue to experience refractory angina despite optimal medical therapy. Recently, stem cell therapy has emerged as a potential therapeutic option for these patients. However, findings of individual trials have been scrutinized because of their small sample sizes and lack of statistical power. Therefore, we conducted an updated comprehensive meta-analysis of available randomized controlled trials (RCTs) with the largest sample size ever reported on this subject.
Hypothesis:
In patients with chronic angina stem cell therapy improves clinical outcomes.
Methods:
Scientific databases and websites were searched for RCTs. Data were independently collected by 2 investigators, and disagreements were resolved by consensus. Data from 10 trials including 658 patients were analyzed.
Results:
Stem cell therapy improved Canadian Cardiovascular Society angina class (risk ratio: 1.53, 95% CI: 1.09 to 2.15, P = 0.013), exercise capacity (standardized mean difference [SMD]: 0.56, 95% CI: 0.23 to 0.88, P = 0.001), and left ventricular ejection fraction (SMD: 0.63, 95% CI: 0.27 to 1.00, P = 0.001) compared with placebo. It also decreased anginal episodes (SMD: -1.21, 95% CI: -2.40 to -0.02, P = 0.045) and myocardial perfusion defects (SMD: -0.70, 95% CI: -1.11 to -0.29, P = 0.001). However, no improvements in all-cause mortality were observed after a relatively short follow-up.
Conclusions:
In patients with chronic angina on optimal medical therapy, stem cell therapy improves symptoms, exercise capacity, and left ventricular ejection fraction. These findings warrant confirmation using larger trials.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Angina I: Introduction
Angina II: Classification
Angina IV: Management
Angina V: Nursing Management
Adult Stem Cells

